{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:41:48Z","timestamp":1790541708996,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Korean Ministry of Health and Welfare Research Fund 2009","award":["#A084610"],"award-info":[{"award-number":["#A084610"]}]},{"name":"Korean Ministry of Health and Welfare Research Fund 2010","award":["#A100236"],"award-info":[{"award-number":["#A100236"]}]},{"name":"National Research Foundation of Korea funded by the Korean government (MESF)","award":["#2011-0030737"],"award-info":[{"award-number":["#2011-0030737"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbadis.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T14:45:17Z","timestamp":1347115517000},"page":"183-194","source":"Crossref","is-referenced-by-count":60,"title":["Pathogenic role of HIF-1\u03b1 in prostate hyperplasia in the presence of chronic inflammation"],"prefix":"10.1016","volume":"1832","author":[{"given":"Hye-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Wan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Suk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Seon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Sook","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2012.09.002_bb0005","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary","year":"2006","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijir.2008.55","article-title":"Pathology of benign prostatic hyperplasia","volume":"20","author":"Roehrborn","year":"2008","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.beem.2008.01.016","article-title":"5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction","volume":"22","author":"Rittmaster","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0039-128X(94)90016-7","article-title":"5Alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia","volume":"59","author":"Weisser","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0025","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1 is mediated by an O-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0040","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1196\/annals.1422.035","article-title":"Regulation of cytokine-induced HIF-1 expression in rheumatoid synovial fibroblasts","volume":"1108","author":"Westra","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1152\/physiol.00001.2004","article-title":"Hydroxylation of HIF-1: oxygen sensing at the molecular level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0065","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/pros.20641","article-title":"HIF-1\u03b1 promotes survival of prostate cells at a high zinc environment","volume":"67","author":"Park","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/pros.21152","article-title":"Survivin mediates prostate cell protection by HIF-1alpha against zinc toxicity","volume":"70","author":"Yun","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jnutbio.2009.06.004","article-title":"Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1\u03b1","volume":"21","author":"Li","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<45::AID-PROS6>3.0.CO;2-W","article-title":"Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition","volume":"42","author":"Shibata","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pros.20080","article-title":"Serum sex hormones and measures of benign prostatic hyperplasia","volume":"61","author":"Roberts","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1464-410X.1971.tb12050.x","article-title":"Chronic prostatitis in benign prostatic hyperplasia","volume":"43","author":"Odunjo","year":"1971","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","article-title":"Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study","volume":"121","author":"Kohnen","year":"1979","journal-title":"J. Urol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","article-title":"Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia","volume":"84","author":"Nickel","year":"1999","journal-title":"BJU Int."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cdp.2008.02.007","article-title":"Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer","volume":"32","author":"Bouraoui","year":"2008","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","article-title":"Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate","volume":"56","author":"Steiner","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0115","first-page":"119","article-title":"Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression","volume":"11","author":"Royuela","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0125","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial\u2013mesenchymal transitions","volume":"119","author":"Zeisberq","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0145","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"Di Silverio","year":"2003","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0155","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","article-title":"Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value","volume":"157","author":"Irani","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2007.09.013","article-title":"Prostate growth and inflammation","volume":"108","author":"Sciarra","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0165","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.0902401","article-title":"TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types","volume":"184","author":"Galli","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/pros.20984","article-title":"Expression of Toll-like receptor 4 n the prostate gland and its association with the severity of prostate cancer","volume":"69","author":"Gatti","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.10317","article-title":"Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer","volume":"58","author":"K\u00f6nig","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0180","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","article-title":"The transcription factor Snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression","volume":"2","author":"Cano","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/emmm.200900043","article-title":"Inflammation and EMT: an alliance towards organ fibrosis and cancer progression","volume":"1","author":"L\u00f3pez-Novoa","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0200","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: When epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0205","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/pros.21350","article-title":"TGF-\u03b21-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2\/Slug","volume":"71","author":"Slab\u00e1kov\u00e1","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0210","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.0812666106","article-title":"A role for epithelial\u2013mesenchymal transition in the etiology of benign prostatic hyperplasia","volume":"106","author":"Alonso-Maqdalena","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1593\/neo.04241","article-title":"Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro","volume":"6","author":"Xie","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbadis.2012.09.002_bb0220","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1016\/j.febslet.2006.09.003","article-title":"JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes","volume":"580","author":"Santiba\u00f1ez","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0225","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0230","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.071647","article-title":"p38 maintains E-cadherin expression by modulating TAK1\u2013NF-\u03baB during epithelial-to-mesenchymal transition","volume":"123","author":"Strippoli","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0235","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2012.09.002_bb0240","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1593\/neo.91326","article-title":"Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis","volume":"11","author":"Huang","year":"2009","journal-title":"Neoplasia"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443912002116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443912002116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T14:07:03Z","timestamp":1643378823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443912002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0925443912002116"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2012.09.002","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}